Jiao Mo

Also affiliated with West China Hospital of Sichuan University, Thermo Fisher Scientific (Israel)

Biochemistry, Genetics and Molecular BiologyMedicineNursing

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Proteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells”.

Proteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells

Nature Communications(2021)10.1038/s41467-021-21573-x

N/A

0DataRank · unranked

55 citations

Umasankar De, Sajid Khan, Yuewan Luo, Myung‐Chul Kim, Haijun Yu +14 more

The distinct roles of MSH2 and MLH1 in basal-like breast cancer and immune modulation

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.20.549745

N/A

0DataRank · unranked

2 citations

Jiao Mo, Nicholas Borcherding, Sung Duk Jo, Heather R Kates, Edward H. Cho +12 more

Unleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer Immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.09.552650

N/A

0DataRank · unranked

0 citations

Yufeng Xiao, Yuewan Luo, Rohan Master, Jiao Mo, Myung‐Chul Kim +11 more

PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy

The Journal of Experimental Medicine(2024)10.1084/jem.20231519

N/A

0DataRank · unranked

28 citations

Yufeng Xiao, Yuewan Luo, Rohan Master, Jiao Mo, Myung‐Chul Kim +17 more

Contrasting roles of MutSα and MutLα in basal-like breast cancer 3317

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1133

N/A

0DataRank · unranked

0 citations

Jiao Mo, Ryan Kolb, Weizhou Zhang, Tanzia Islam Tithi